|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
World Health Organization (WHO), . Fact Sheet Cancer, 2021. WHO; Geneva: 2021, https://www.who.int/news-room/fact-sheets/detail/cancerAugust 8–2021
|
|
3
|
Chien N, Chen JY, Chen SJ and Chang YC: The third Asian radiology forum: Screening programs in Asia. Korean J Radiol. 21:119–124. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Denisenko TV, Budkevich IN and Zhivotovsky B: Cell death-based treatment of lung adenocarcinoma. Cell Death Dis. 9:1172018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cragg GM and Newman DJ: Plants as a source of anti-cancer agents. J Ethnopharmacol. 100:72–79. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Prucksunand C, Indrasukhsri B, Leethochawalit M and Hungspreugs K: Phase II clinical trial on effect of the long turmeric (Curcuma longa Linn) on healing of peptic ulcer. Southeast Asian J Trop Med Public Health. 32:208–215. 2001.PubMed/NCBI
|
|
7
|
Toyang NJ and Verpoorte R: A review of the medicinal potentials of plants of the genus Vernonia (Asteraceae). J Ethnopharmacol. 146:681–723. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Smitinand T: Thai plant names (Botanical Names-Vernacular Names). Rong pim Buddha press; Bangkok: pp. 2802014
|
|
9
|
Egharevba C, Osayemwenre E, Imieje V, Ahomafor J, Akunyuli C, Udu-Cost AA, Theophilus O, James O, Ali I and Falodun A: Significance of bitter leaf (Vernonia amagdalina) in tropical diseases and beyond: A review. Malar Chemoth Cont. 3:1202014.
|
|
10
|
Ong KW, Hsu A, Song L, Huang D and Tan BK: Polyphenols-rich Vernonia amygdalina shows anti-diabetic effects in streptozotocin-induced diabetic rats. J Ethnopharmacol. 133:598–607. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Quasie O, Zhang YM, Zhang HJ, Luo J and Kong LY: Four new steroid saponins with highly oxidized side chains from leaves of Vernonia amygdalina. Phytochem Lett. 15:16–20. 2016. View Article : Google Scholar
|
|
12
|
Igual MO, Martucci ME, Da Costa FB and Gobbo-Neto L: Sesquiterpene lactones, chlorogenic acids and flavonoids from leaves of Vernonia polyanthes less (Asteraceae). Biochem Syst Ecol. 51:94–97. 2013. View Article : Google Scholar
|
|
13
|
Chea A, Hout S, Long C, Marcourt L, Faure R, Azas N and Elias R: Antimalarial activity of sesquiterpene lactones from vernonia cinerea. Chem Pharm Bull (Tokyo). 54:1437–1439. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Youn UJ, Park EJ, Kondratyuk TP, Simmons CJ, Borris RP, Tanamatayarat P, Wongwiwatthananukit S, Toyama O, Songsak T, Pezzuto JM and Chang LC: Anti-inflammatory sesquiterpene lactones from the flower of vernonia cinerea. Bioorg Med Chem Lett. 22:5559–5562. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen QF, Liu ZP and Wang FP: Natural sesquiterpenoids as cytotoxic anticancer agents. Mini Rev Med Chem. 11:1153–1164. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Thongnest S, Chawengrum P, Keeratichamroen S, Lirdprapamongkol K, Eurtivong C, Boonsombat J, Kittakoop P, Svasti J and Ruchirawat S: Vernodalidimer L, a sesquiterpene lactone dimer from Vernonia extensa and anti-tumor effects of vernodalin, vernolepin, and vernolide on HepG2 liver cancer cells. Bioorg Chem. 92:1031972019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yuan L, Zhang Y, Xia J, Liu B, Zhang Q, Liu J, Luo L, Peng Z, Song Z and Zhu R: Resveratrol induces cell cycle arrest via a p53-independent pathway in A549 cells. Mol Med Rep. 11:2459–2464. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chiang SR, Lin CS, Lin HH, Shieh PC and Kao SH: Bergapten induces G1 arrest of nonsmall cell lung cancer cells, associated with the p53 mediated cascade. Mol Med Rep. 19:1972–1978. 2019.PubMed/NCBI
|
|
19
|
Wang S, Hu Y, Yan Y, Cheng Z and Liu T: Sotetsuflavone inhibits proliferation and induces apoptosis of A549 cells through ROS-mediated mitochondrial-dependent pathway. BMC Complement Altern Med. 18:2352018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rukkijakan T, Ngiwsara L, Lirdprapamongkol K, Svasti J, Phetrak N and Chuawong P: A synthetic 2,3-diarylindole induces cell death via apoptosis and autophagy in A549 lung cancer cells. Bioorg Med Chem Lett. 26:2119–2123. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Keeratichamroen S, Lirdprapamongkol K and Svasti J: Mechanism of ECM-induced dormancy and chemoresistance in A549 human lung carcinoma cells. Oncol Rep. 39:1765–1774. 2018.PubMed/NCBI
|
|
22
|
Hsu KC, Chen YF, Lin SR and Yang JM: iGEMDOCK: A graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis. BMC Bioinformatics. 12 (Suppl 1):S332011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC and Ferrin TE: UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem. 25:1605–1612. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu M, Xiao C, Sun M, Tan M, Hu L and Yu Q: Parthenolide inhibits STAT3 signaling by covalently targeting Janus kinases. Molecules. 23:14782018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kupchan SM, Hemingway RJ, Karim A and Werner D: Tumor inhibitors. XLVII. Vernodalin and vernomygdin, two new cytotoxic sesquiterpene lactones from Vernonia amygdalina Del. J Org Chem. 34:3908–3911. 1969. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kupchan SM, Hemingway RJ, Werner D and Karim A: Tumor inhibitors. XLVI. Vernolepin, a novel sesquiterpene dilactone tumor inhibitor from Vernonia hymenolepis A. rich. J Org Chem. 34:3903–3907. 1969. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Laekeman GM, De Clerck F, Vlietinck AJ and Herman AG: Vernolepin: An antiplatelet compound of natural origin. Naunyn Schmiedebergs Arch Pharmacol. 331:108–113. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zenebe MM, Dessie KB, Hana GM and Werkneh AA: Isolation, structural elucidation, and bioactivity studies of leaf extract of Vernonia amygdalina. Am J Appl Chem. 3:14–20. 2015. View Article : Google Scholar
|
|
29
|
Chukwujekwu JC, Lategan CA, Smith PJ, Van Heerden FR and Van Staden J: Antiplasmodial and cytotoxic activity of isolated sesquiterpene lactones from the acetone leaf extract of Vernonia colorata. S Afr J Bot. 75:176–179. 2009. View Article : Google Scholar
|
|
30
|
Erasto P, Grierson DS and Afolayan AJ: Bioactive sesquiterpene lactones from the leaves of Vernonia amygdalina. J Ethnopharmacol. 106:117–120. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Quitschke WW: Curcuminoid binding to embryonal carcinoma cells: Reductive metabolism, induction of apoptosis, senescence, and inhibition of cell proliferation. PLoS One. 7:e395682012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wong RS: Apoptosis in cancer: From pathogenesis to treatment. J Exp Clin Cancer Res. 30:872011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ewald JA, Desotelle JA, Wilding G and Jarrard DF: Therapy-induced senescence in cancer. J Natl Cancer Inst. 102:1536–1546. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhu H and Gooderham NJ: Mechanisms of induction of cell cycle arrest and cell death by cryptolepine in human lung adenocarcinoma a549 cells. Toxicol Sci. 91:132–139. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen J, Wang J, Lin L, He L, Wu Y, Zhang L, Yi Z, Chen Y, Pang X and Liu M: Inhibition of STAT3 signaling pathway by nitidine chloride suppressed the angiogenesis and growth of human gastric cancer. Mol Cancer Ther. 11:277–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li J, Kent DG, Chen E and Green AR: Mouse models of myeloproliferative neoplasms: JAK of all grades. Dis Model Mech. 4:311–317. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Huang WW, Yang JS, Lin MW, Chen PY, Chiou SM, Chueh FS, Lan YH, Pai SJ, Tsuzuki M, Ho WJ and Chung JG: Cucurbitacin E induces G(2)/M phase arrest through STAT3/p53/p21 signaling and provokes apoptosis via Fas/CD95 and Mitochondria- dependent pathways in human bladder cancer T24 cells. Evid Based Complement Alternat Med. 2012:9527622012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhou C, Ma J, Su M, Shao D, Zhao J, Zhao T, Song Z, Meng Y and Jiao P: Down-regulation of STAT3 induces the apoptosis and G1 cell cycle arrest in esophageal carcinoma ECA109 cells. Cancer Cell Int. 18:532018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kim JY, Choi JA, Kim TH, Yoo YD, Kim JI, Lee YJ, Yoo SY, Cho CK, Lee YS and Lee SJ: Involvement of p38 mitogen-activated protein kinase in the cell growth inhibition by sodium arsenite. J Cell Physiol. 190:29–37. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kang N, Wang MM, Wang YH, Zhang ZN, Cao HR, Lv YH, Yang Y, Fan PH, Qiu F and Gao XM: Tetrahydrocurcumin induces G2/M cell cycle arrest and apoptosis involving p38 MAPK activation in human breast cancer cells. Food Chem Toxicol. 67:193–200. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lepley DM and Pelling JC: Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin. Mol Carcinog. 19:74–82. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu H, Li Z, Huo S, Wei Q and Ge L: Induction of G0/G1 phase arrest and apoptosis by CRISPR/Cas9-mediated knockout of CDK2 in A375 melanocytes. Mol Clin Oncol. 12:9–14. 2020.PubMed/NCBI
|
|
43
|
Siu WY, Yam CH and Poon RY: G1 versus G2 cell cycle arrest after adriamycin-induced damage in mouse Swiss3T3 cells. FEBS Lett. 461:299–305. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sinisi A, Millán E, Abay SM, Habluetzel A, Appendino G, Muñoz E and Taglialatela-Scafati O: Poly-Electrophilic Sesquiterpene Lactones from Vernonia amygdalina: New members and differences in their mechanism of thiol trapping and in bioactivity. J Nat Prod. 78:1618–1623. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hsieh FC, Cheng G and Lin J: Evaluation of potential Stat3-regulated genes in human breast cancer. Biochem Biophys Res Commun. 335:292–299. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lirdprapamongkol K, Sakurai H, Abdelhamed S, Yokoyama S, Athikomkulchai S, Viriyaroj A, Awale S, Ruchirawat S, Svasti J and Saiki I: Chrysin overcomes TRAIL resistance of cancer cells through Mcl-1 downregulation by inhibiting STAT3 phosphorylation. Int J Oncol. 43:329–337. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sun CY, Nie J, Huang JP, Zheng GJ and Feng B: Targeting STAT3 inhibition to reverse cisplatin resistance. Biomed Pharmacother. 117:1091352019. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lankadasari MB, Aparna JS, Mohammed S, James S, Aoki K, Binu VS, Nair S and Harikumar KB: Targeting S1PR1/STAT3 loop abrogates desmoplasia and chemosensitizes pancreatic cancer to gemcitabine. Theranostics. 8:3824–3840. 2018. View Article : Google Scholar : PubMed/NCBI
|
